Nai-Kong Cheung is head of the neuroblastoma program at MSKCC. Said he’s encouraged by t-cell approaches, and other new technologies, even given the hurdle of little to no HLA expression.pic.twitter.com/H3Oh61Jsdd

13:35 EDT 5 Oct 2018 | Brad Loncar

Nai-Kong Cheung is head of the neuroblastoma program at MSKCC. Said he’s encouraged by t-cell approaches, and other new technologies, even given the hurdle of little to no HLA expression. pic.twitter.com/H3Oh61Jsdd

More From BioPortfolio on "Nai-Kong Cheung is head of the neuroblastoma program at MSKCC. Said he’s encouraged by t-cell approaches, and other new technologies, even given the hurdle of little to no HLA expression.pic.twitter.com/H3Oh61Jsdd"